$19.98
Value $13.9B
DOC and EQIX stock compared: price, dividend, valuation and results, from SEC filings.
$19.98
Value $13.9B
$1,053.79
Value $104B
Healthpeak Properties (DOC) has a market value of $13.9B and Equinix (EQIX) $104B. Over the last year, with dividends, DOC moved +21.6% and EQIX +32.3%. The P/E is 36.8 for DOC and 62.8 for EQIX. Dividend yield: DOC 6.13%, EQIX 1.91%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
DOC$13.9B
EQIX$104B
EQIX is 7.5 times DOC
Revenue, 12 months
DOC$3.1B
EQIX$10.1B
EQIX is 3.3 times DOC
Net income, 12 months
DOC$378M
EQIX$1.6B
EQIX is 4.4 times DOC
Operating margin
DOC–
EQIX22.5%
ROIC
DOC1.9%
EQIX5.9%
4.0 points apart
P/E
DOC36.8
EQIX62.8
EQIX is 1.7 times DOC
Dividend yield
DOC6.1%
EQIX1.9%
4.2 points apart
5-year return
DOC-21.3%
EQIX+50.1%
71.4 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
DOC-21.3%
EQIX+50.1%
| Period | DOCWith dividends | EQIXWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +21.6%Price +13.3% | +32.3%Price +29.6% |
| 3 years since November 13, 2023 | +54.8%+15.7% a yearPrice +28.3% | +47.2%+13.8% a yearPrice +38.2% |
| 5 years since November 12, 2021 | -21.3%-4.7% a yearPrice -40.9% | +50.1%+8.5% a yearPrice +35.9% |
| 10 years since November 15, 2016 | +15.3%+1.4% a yearPrice -32.1% | +277.9%+14.2% a yearPrice +213.3% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
DOCHealthpeak PropertiesEQIXEquinix
| Price | $19.98 | $1,053.79 |
|---|---|---|
| Market value | $13.9B | $104B |
| Enterprise value (EV) | $22.8B | $125B |
| P/E | 36.8 | 62.8 |
| P/E, 5-year median | 37.1 | 78.1 |
| P/B | 1.8 | 7.1 |
| EV/EBIT | 54.9 | 55.3 |
| Free cash flow yield | 2.6% | – |
| Revenue, 12 months | $3.1B | $10.1B |
|---|---|---|
| Net income, 12 months | $378M | $1.6B |
| Free cash flow, 12 months | $357M | -$1.7B |
| Earnings per share, 12 months | $0.54 | $16.65 |
| Revenue growth, year on year | 4.5% | 5.4% |
| Revenue growth a year, past | +11.4%over 5 years | +9.0%over 5 years |
| EPS growth a year, past | -33.5%over 5 years | +26.9%over 5 years |
| Gross margin | 63.5% | 51.6% |
|---|---|---|
| Operating margin | – | 22.5% |
| Net margin | 12.3% | 16.4% |
| ROIC | 1.9% | 5.9% |
| ROE | 4.9% | 11.5% |
| Cash | $514M | $3.6B |
|---|---|---|
| Total debt | $9.7B | $26.6B |
| Net debt / EBITDA | 6.0 | 5.0 |
| Interest cover | 1.2× | 3.8× |
| Dividend yield | 6.1% | 1.9% |
|---|---|---|
| Dividend per share, 12 months | $1.22 | $20.17 |
| Dividend growth a year, past | -3.8%over 5 years | +12.0%over 5 years |
| Buyback yield | 0.7% | – |
| Shareholder yield | 6.8% | 1.9% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Equinix ($104B) is about 7.5 times Healthpeak Properties ($13.9B), at today's prices.
Since November 15, 2016, DOC's price moved -32.1% and EQIX's +213.3%. With dividends: DOC +15.3% (+1.4% a year), EQIX +277.9% (+14.2% a year). Past returns do not predict future ones.
The dividend yield at today's price is 6.13% for Healthpeak Properties and 1.91% for Equinix. Over the last twelve months they paid $1.22 and $20.17 per share.
At today's price, the P/E is 36.8 for DOC and 62.8 for EQIX. The median of the last five years was 37.1 and 78.1, which shows where each stands against its own past.
Over the last twelve months, the net margin was 12.3% for Healthpeak Properties and 16.4% for Equinix, and the operating margin – and 22.5%. Revenue was $3.1B and $10.1B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.